is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Launched in 1997, the Pharmapack Awards celebrate the latest innovations from packaging companies within the drugs, medical devices, health products and veterinary drugs sectors.
These prestigious awards take place annually alongside the Pharmapack Europe exhibition and conference and recognise pioneering packaging innovations that have significantly contributed to improving the following elements:
The SKYTROFA Auto-Injector provides a fully automated reconstitution of
the lyophilized SKYTROFA drug product which is followed by a manual mixing step
controlled by the device. When the injection needle is inserted into the skin,
the device automatically delivers the drug product. The built-in electronics
and software assist the user during the entire preparation and injection
sequence and provide confirmation that the full dose has been delivered.
SKYTROFA is injected subcutaneously into the abdomen, buttock, or thigh.
TouStar® is the first reusable pen injector intended for delivery of concentrated insulin. TouStar®
has been developed specifically to improve access to Sanofi’s Toujeo®, which is
a three-times concentrated basal insulin. With this concentration, a Toujeo®
cartridge that is only half the size of a regular one contains 50% more
Aria is a novel reusable electronic autoinjector, designed to meet current and emerging needs of the self-injection market for biopharmaceuticals. It consists of a reusable electronic power unit, coupled with a disposable cassette, which contains either a 1ml or 2.25mL pre-filled syringe and provides needle safety, using a moveable shield, similar to most disposable devices. The reusable format significantly improves sustainability over conventional disposable autoinjectors, offers built in Bluetooth connectivity and clear audible and visual feedback to guide users through the injection process. It is being developed as a device platform for multiple therapies and pharmaceutical customers
YpsoMate On is the world’s first pre-filled autoinjector with integrated connectivity that automatically logs injections on the user’s therapy management app. This new autoinjector adds connectivity but retains the market-proven 2-step handling of the YpsoMate autoinjector platform. YpsoMate On includes an advanced Bluetooth proximity measurement protocol which automatically connects the injection device and the smartphone. This simplifies the user journey by removing the need for pairing. The injection data is automatically transferred to the user's therapy management app and the associated cloud. As such, YpsoMate On provides connectivity without compromising ease-of-use.
Our product is the “IoT Pixel”: a battery-free Bluetooth enabled smart label that powers itself by harvesting RF energy. By sticking a pixel onto plastic crates, pharmaceuticals, and packaging, they are instantly connected to the IoT; giving them constant connectivity, sensing, and visibility. This added intelligence will change the way they are made, distributed, sold, used, reused, and recycled.
Activated RispharmTM is a multidose eye dropper with nozzle and cap activated to kill bacteria and viruses continuously to deliver hygienic doses at each use and thus, to reduce infection risks. It offers the market with unprecedented competitive advantages in terms of patients’ protection, time-to-market and sustainability
- Proven and certified mineral antimicrobial protection of dropper tip (85% of contaminations)- Hygienic applications for every use with a multidose dropper- Reduces the amount of plastic waste by 16 x for one month treatment compared to monodose- No change in patient treatment methods- Certified non-irritant and non-cytotoxic technology